Zobrazeno 1 - 10
of 19
pro vyhledávání: '"T B, Hakes"'
Publikováno v:
Cancer. 75(8)
Circulating immune complexes (CIC) have been implicated as a cause of malignancy-associated immunosuppression and disease progression. Previous attempts to remove CIC by pheresis or immunoadsorption over a Staphylococcus aureus protein A column have
Autor:
A Surbone, Bonnie Reichman, V Currie, Andrew D. Seidman, J P Crown, T B Hakes, Robert T. Heelan, Clifford A. Hudis, Teresa Gilewski, D E Lebwohl
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 11(10)
PURPOSE A phase II study of Taxol (paclitaxel; Bristol-Myers Squibb Co, Princeton, NJ) as initial chemotherapy for metastatic breast cancer was conducted. Recombinant human granulocyte colony-stimulating factor (rhG-CSF) was used to ameliorate myelos
Autor:
A D, Seidman, L, Norton, B S, Reichman, J P, Crown, T J, Yao, R, Heelan, T B, Hakes, D E, Lebwohl, T A, Gilewski, A, Surbone
Publikováno v:
Seminars in oncology. 20(4 Suppl 3)
Single-agent paclitaxel (TAXOL) was administered to 79 patients with stage IV breast cancer. Twenty-eight patients had no prior chemotherapy (for metastatic disease), and 51 patients had extensive exposure to other chemotherapeutic agents before begi
Publikováno v:
Obstetrics and gynecology. 82(1)
To evaluate the role of second-look laparotomy in patients with comprehensively staged stage I epithelial ovarian cancer.We reviewed the medical records and obtained long-term follow-up on 54 stage I patients who had second-look laparotomies followin
Autor:
A D, Seidman, B S, Reichman, J P, Crown, T J, Yao, R, Heelan, T B, Hakes, D E, Lebwohl, T A, Gilewski, A, Surbone, V, Currie
Publikováno v:
Journal of the National Cancer Institute. Monographs. (15)
Twenty-eight patients received Taxol as their first chemotherapy for stage IV breast cancer. An additional 51 patients with extensive prior exposure to other chemotherapeutic agents received Taxol as salvage therapy. We found significant activity for
Publikováno v:
Cancer. 66(8)
The relationship between percent of ideal dose and disease-free survival was examined in 256 Stage II and III patients who participated in a 2-year breast adjuvant chemotherapy trial consisting of cyclophosphamide, methotrexate, and 5-fluorouracil (C
Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancer
Autor:
D H, Bovbjerg, W H, Redd, L A, Maier, J C, Holland, L M, Lesko, D, Niedzwiecki, S C, Rubin, T B, Hakes
Publikováno v:
Journal of consulting and clinical psychology. 58(2)
Nausea and immune function were assessed in 20 cancer patients in the hospital prior to chemotherapy and compared with assessments conducted at home. Proliferative responses to T-cell mitogens were lower for cells isolated from hospital blood samples
Publikováno v:
Cancer. 51(5)
The effect of CMF adjuvant therapy (cyclophosphamide, methotrexate, and 5-fluorouracil) on endocrine function was investigated in breast cancer patients. CMF therapy resulted in suppression of ovarian function in some premenopausal patients but pitui
Publikováno v:
Cancer. 50(6)
Seventeen patients with malignant ovarian germ cell tumors were treated with vinblastine, actinomycin D, bleomycin and cisplatin containing combinations. Many of these patients were heavily pretreated. Thirteen patients had objectively measurable dis
Publikováno v:
Cancer treatment reports. 71(12)